Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
It is particularly beneficial after injuries, showing promise in animal studies for speeding up recovery processes, including complete transections of tissues 1
This multi-system activity is what distinguishes BPC-157 from narrower agents
Second, the final maintenance dose may be lower than what you would use with retatrutide alone, because the cagrilintide component provides additional appetite suppression and metabolic benefit that reduces the need for maximum retatrutide dosing
Being Inconsistent with Timing and Frequency Peptides work best when taken consistently , as their short half-lives require regular administration to maintain stable therapeutic levels
As of February 2026, BPC-157 returned to Category 1 compounding status
